Skip to main content

Table 3 Treatment provided and outcome in the groups of patients treated with different dialysis modalities, IHD versus CRRT (n = 81)

From: Intermittent versus continuous renal replacement therapy in acute methanol poisoning: comparison of clinical effectiveness in mass poisoning outbreaks

  Treatment given Complications and outcome
Group of patients Ethanol, n (%) Fomepizole, n (%) Alkalinization, n (%) HD start, hours HD duration, hours Folate therapy, n (%) Complications, n (%) ICU LOS, days Survivors without sequelae Survived with sequelae Died, n (%)
IHD (n = 41; 9F) 28 (68%) 13 (32%) 24 (59%) 2.5 ± 0.6 9.1 ± 2.4 31 (76%) 11 (27%) 4 (1–16) 23 (56%) 13 (32%) 5 (12%)
CRRT (n = 40; 8F) 27 (68%) 12 (30%) 33 (83%) 3.5 ± 0.9 45.7 ± 9.7 34 (86%) 13 (33%) 4 (1–22) 10 (25%) 15 (37.5%) 15 (37.5%)
Total (n = 81) 55 (68%) 25 (31%) 57 (70%) 3.0 ± 0.6 25.8 ± 6.3 65 (80%) 25 (31%) 4 (1–22) 33 (40%) 28 (35%) 20 (25%)
P IHD/CRRT 0.939 0.868 0.018 0.084 <0.001 0.289 0.576 0.703 0.004 0.584 0.008
  1. Italic text indicates statistically significant result at p < 0.05
  2. IHD intermittent hemodialysis, CRRT continuous renal replacement therapy, HD start—time from hospital admission to ECTR initiation, HD duration—the total duration of RRT sessions (incorporates both single and multiple sessions of IHD), ICU LOS—ICU length of stay (median with range)